Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 952.00p on 11-02-2026 at 06:00:05
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Last Trade: Unknown 2,326.00 at 952.00p
Day's Volume: 0
Last Close: 952.00p
Open: 0.00p
ISIN: GB00BQVXM815
Day's Range 0.00p - 0.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £57.51m
VWAP: 0.00p
Shares in Issue: 6.04m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 2,326 952.00p OTC Trade
17:08:23 - 10-Feb-26
Sell* 125 944.00p Ordinary
16:29:14 - 10-Feb-26
Sell* 500 926.052p Ordinary
16:27:00 - 10-Feb-26
Sell* 200 926.104p Ordinary
16:26:25 - 10-Feb-26
Sell* 10 946.75p Ordinary
16:22:33 - 10-Feb-26
Sell* 386 944.00p Ordinary
16:16:57 - 10-Feb-26
Sell* 156 944.00p Ordinary
16:15:55 - 10-Feb-26
Buy* 1 976.00p SI Trade
16:11:50 - 10-Feb-26
Sell* 125 951.5712p Ordinary
16:04:49 - 10-Feb-26
Sell* 238 930.00p Automatic Execution
16:04:27 - 10-Feb-26
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Feb 2026 (Wed) 952.00 952.00 952.00 952.00 0
10th Feb 2026 (Tue) 848.00 1,100.00 796.00 952.00 109,206
9th Feb 2026 (Mon) 1,155.00 1,160.00 860.00 915.00 73,083
6th Feb 2026 (Fri) 992.00 1,145.00 992.00 1,100.00 92,868
5th Feb 2026 (Thu) 900.00 992.00 820.00 992.00 91,711
4th Feb 2026 (Wed) 830.00 880.00 810.00 842.00 29,074
3rd Feb 2026 (Tue) 732.00 830.00 732.00 800.00 24,765
2nd Feb 2026 (Mon) 732.00 842.00 702.00 740.00 47,235
30th Jan 2026 (Fri) 788.00 788.00 612.00 736.00 86,474
29th Jan 2026 (Thu) 788.00 856.00 758.00 789.00 20,141
28th Jan 2026 (Wed) 864.00 930.00 800.00 818.00 72,806
27th Jan 2026 (Tue) 650.00 850.00 650.00 804.00 91,767
26th Jan 2026 (Mon) 694.00 694.00 694.00 676.00 18,886
23rd Jan 2026 (Fri) 670.00 674.00 670.00 674.00 14,778
22nd Jan 2026 (Thu) 662.00 700.00 654.00 681.00 17,972
21st Jan 2026 (Wed) 642.00 694.00 642.00 668.00 12,739
20th Jan 2026 (Tue) 602.00 688.00 602.00 688.00 15,327
19th Jan 2026 (Mon) 636.00 636.00 600.00 627.00 10,870
16th Jan 2026 (Fri) 610.00 642.00 608.00 625.00 8,223
15th Jan 2026 (Thu) 650.00 652.00 602.00 627.00 22,329
14th Jan 2026 (Wed) 652.00 652.00 636.00 636.00 6,037
13th Jan 2026 (Tue) 612.00 654.00 612.00 638.00 20,885
12th Jan 2026 (Mon) 618.00 642.00 600.00 631.00 27,984
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
10th Feb 2026 3:52 pm RNS Issue of Equity - Correction
10th Feb 2026 7:00 am RNS Issue of Equity
30th Jan 2026 7:00 am RNS Total Voting Rights
12th Jan 2026 7:00 am RNS Holding(s) in Company
22nd Dec 2025 8:00 am RNS Update on Admission of Shares
18th Dec 2025 7:00 am RNS Issue of Equity
8th Dec 2025 12:48 pm RNS Holding(s) in Company
28th Nov 2025 7:00 am RNS Total Voting Rights
19th Nov 2025 11:47 am RNS Publication of Prospectus
29th Oct 2025 7:00 am RNS Clinical Trial Update and Grant of Share Awards
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows

10th Feb 2026 19:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise

10th Feb 2026 12:12

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with the FTSE 100 edging lower as investors weighed a busy flow of company news while mid-cap stocks held up better. Read More

SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials

10th Feb 2026 10:46

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value10,353.84
Change0.00

Login to your account

Forgot Password?

Not Registered